Clinical Trial Update: Esprit BTK Post-Approval Study [NA]

View source ↗

Summary

Update on Abbott's Esprit BTK post-approval study in chronic limb-threatening ischemia. The trial status is ACTIVE_NOT_RECRUITING.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Limb-threatening Ischemia

Drugs mentioned

• Esprit BTK

Snippet

Sponsor: Abbott Medical Devices | Conditions: Chronic Limb-Threatening Ischemia | NA | Status: ACTIVE_NOT_RECRUITING